RUA Life Sciences plc (FRA:AOHA)

Market Cap	12.76M +46.1%
Revenue (ttm)	5.11M +74.5%
Net Income	-166.50K
EPS	-0.00
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.1660
Previous Close	0.1710
Day's Range	0.1660 - 0.1660
52-Week Range	0.0815 - 0.2560
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 2, 2026

About RUA Life Sciences

RUA Life Sciences plc, together with its subsidiaries, develops medical devices in Europe, North America, the Middle East, the Asia Pacific, and Africa. It operates through four segments: Biomaterials, Contract Manufacture, Vascular, and Structural Heart. The company acts as the depository of intellectual property and licensing rights to various biostable and implantable polymers, including Elast-Eon and ECSil; and provides sub-contract manufacturing, assembly, packing, and services of medical device, as well as implantable fabric. It also enga...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1996
• Employees: 59
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: AOHA

Financial Performance

Financial numbers in GBP

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Jun 26, 2026

Data Sources Report a data error